Eyepulse Pharma Private Limited - Company Profile

It is a trading private limited company based in Kanpur, Uttar Pradesh, India, established in 2019.
2019 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Eyepulse Pharma Private Limited

Eyepulse Pharma Private Limited, a active private limited company, was established on 11 January 2019 in Kanpur, Uttar Pradesh, India. Engaging in specialty within the trading sector, it holds CIN: U51909UP2019PTC112263. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Neetu Bajpai (Director), Ashish Kumar Bajpai (Director). Past directors included Neetu Bajpai, Prateek Tiwari. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 142, Yashoda Nagar, Kanpur, Uttar Pradesh, 208011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909UP2019PTC112263

  • Registration Number

    112263

  • Incorporation Date

    11 January 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 28 Days
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth **** 0.19%
  • Profit Growth **** -20.82%
  • Ebitda **** 105.58%
  • Net Worth 2.78%
  • Total Assets -0.21%
Company report

Eyepulse Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eyepulse Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Eyepulse Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Neetu Bajpai Director 16 Sep 2020 Current
Ashish Kumar Bajpai Director 11 Jan 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Director 27 Aug 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eyepulse Pharma.

Eyepulse Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.19% increase. The company also saw a substantial fall in profitability, with a 20.82% decrease in profit. The company's net worth moved up by a moderate rise of 2.78%.

Eyepulse Pharma revenue growth over time
Eyepulse Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.19%
*******
*******
*******
*******
Revenue from Operations
*******
 0.19%
*******
*******
*******
*******
Total Assets
*******
 -0.21%
*******
*******
*******
*******
Profit or Loss
*******
 -20.82%
*******
*******
*******
*******
Net Worth
*******
 2.78%
*******
*******
*******
*******
EBITDA
*******
 105.58%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eyepulse Pharma?

Unlock access to Eyepulse Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Eyepulse Pharma?

Unlock and access historical data on people associated with Eyepulse Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eyepulse Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eyepulse Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eyepulse Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Eyepulse Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.

  • Balance Sheet

    Eyepulse Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Kanpur. was recorded as a recent event.

  • Director Appointment

    Neetu Bajpai was appointed as a Director was appointed as a Director on 16 Sep 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.

  • Director Appointment

    Progress on Ashish Kumar Bajpai was appointed as a Director was appointed as a Director on 11 Jan 2019 & has been associated with this company since 7 years 28 days . was documented.

  • Company Incorporation

    Eyepulse Pharma Private Limited was registered on 11 Jan 2019 with Roc Kanpur & aged 7 years 28 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eyepulse Pharma Private Limited?

The CIN of Eyepulse Pharma Private Limited is U51909UP2019PTC112263.

Where is Eyepulse Pharma Private Limited headquartered?

Eyepulse Pharma Private Limited is headquartered at 142, Yashoda Nagar, Kanpur, Uttar Pradesh, 208011.

When was Eyepulse Pharma Private Limited incorporated?

Eyepulse Pharma Private Limited was incorporated on 11 January 2019.

Who are the current directors of Eyepulse Pharma Private Limited?

The current directors of Eyepulse Pharma Private Limited are

What is the primary industry of Eyepulse Pharma Private Limited?

The primary industry of Eyepulse Pharma Private Limited is Trading.

Is Eyepulse Pharma Private Limited a listed company?

Eyepulse Pharma Private Limited is unlisted.

What is the capital structure of Eyepulse Pharma Private Limited?

The authorized capital of Eyepulse Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Eyepulse Pharma Private Limited?

The compliance status of Eyepulse Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available